Institutional investors purchased a net $1.5 million shares of AGN during the quarter ended March 2016 and now own 90.07% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LONE PINE CAPITAL LLC Bought 1.8 Million shares of Allergan
THE BAUPOST GROUP LLC Bought 1.7 Million shares of Allergan
D. E. SHAW & CO. LP Bought 1.4 Million shares of Allergan